HORIBA UK Ltd, Medical announces that HORIBA, Ltd. (Headquarters in Kyoto, Japan, referred to as HORIBA) and HORIBA Instruments (Headquarters in Irvine, California) has acquired MedTest Holdings, Inc. (Headquarters in Canton, MI, USA, composed of MedTest Dx, Inc., Pointe Scientific, Inc., Clinitox Diagnostix, Inc., and Medical Laboratory Solutions, Inc.).

The acquisition will combine the complementary innovative technology offerings of the HORIBA Medical segment with MedTest Dx technology, Clinitox, and Pointe Scientific’s R&D and manufacturing capabilities, with particular expertise in FDA 510K and CLIA clearances, to address the multidisciplinary requirements of IVD (in-vitro diagnostics) testing customers.

“Our long-term vision and continuous investments coupled with our outstanding employees have resulted in pursuing innovative Chemistry and Immunochemistry technology solutions. I am extremely pleased that this long term vision has resulted in acquiring MedTest,” said Mr. Atsushi Horiba, Chairman & Group CEO of HORIBA, Ltd.

“This acquisition provides HORIBA Medical the opportunity to address the IVD market's multidisciplinary requirements along with the complementary innovative technology of Pointe Scientific and MedTest’s high quality Chemistry solutions. HORIBA Medical will continue offering innovative technology solutions through its Yumizen brand and current distribution channels,” said HORIBA Medical segment leader Dr. Jai Hakhu, Chairman and CEO of HORIBA Instruments Incorporated and President of HORIBA ABX SAS in France.

HORIBA Medical will continue investing in innovative technologies for future IVD requirements.

About MedTest Dx

MedTest Dx is a world Leader in chemistry reagents manufacturing and diagnostic solutions for decentralized clinical testing, providing a combination of screening instruments and reagent manufacturing in medical technologies, with a wide portfolio of products for IVD testing laboratories.

About HORIBA UK Ltd - Medical

Resulting from over 30 years of understanding and meeting its customers’ individual needs, the HORIBA UK Ltd Medical team holds a wealth of expertise and is a well-respected and renowned specialist in the design, manufacture and support of automated in vitro diagnostic systems.

HORIBA Medical facilitates the entire analytical process, both in the laboratory and at the point of care, from process and analyser optimisation, analysing samples and managing data to remote monitoring and e-Learning. Furthermore, in addition to NHS and private healthcare settings, HORIBA Medical products are proving their worth in many other areas, including: sports science, food and beverage, pharma and nutraceuticals, and clinical research.

HORIBA Medical’s product and service combinations all deliver quality results, flexibility, security and process efficiency.  These merits in turn ensure effective clinical decision making, enhanced patient care pathways and improved patient outcomes.

more news from HORIBA